Regardless of the exact mechanism by which AR/p52-02 interferes, the reduction of pARser81 nuclear translocation and decreased stability of AR caused by the inhibitor likely were major factors in the decrease in AR transcriptional activity and associated inhibition of growth of the prostate cancer cells under the androgen deprived condition. The gene discussed is AR; the disease is prostate carcinoma.